期刊文献+

他汀类药物的临床应用 被引量:1

Clinical application of statins
原文传递
导出
摘要 他汀类药传统上是作为调脂药应用的,4S研究确立了他汀类药在心脑血管病中治疗及预防的地位,并形成调脂外多功能效应的理论。冠心病患者在心血管病事件后,β受体阻滞剂及阿司匹林各降低心血管病病死率25%,而他汀类药物治疗,可降低42%,作用强度最大,被誉为"心脏药物"〔1〕。经20余年临床实践,治疗适应症不断拓宽,有多种疾病能在治疗中获益且安全可靠。为更好地应用他汀类药物,将有关问题综述如下。 Statins are traditionally applied as a lipid-lowering drug,4 Sstudy established the position of statins in heart and brain disease treatment and prevention,and the formation of multi-functional theory beyond lipid lowering effects.CHD patients after heart disease events,β-blockers and aspirin to reduce cardiovascular disease mortality for each 25%,while statin therapy,can reduce by 42%,the role of the maximum intensity,known as the "heart medicine" After 20 years of clinical practice,therapeutic indications continue to expand,there are a variety of diseases can benefit from a reliable and safe in the treatment.
作者 李涛 张丛
出处 《临床急诊杂志》 CAS 2014年第4期241-244,共4页 Journal of Clinical Emergency
关键词 他汀类药 临床应用 安全性 statins clinical application security
  • 相关文献

参考文献30

  • 1徐成斌.冠心病防治在调脂领域的某些进展与动向[J].心血管病学进展,2002,23(1):1-5. 被引量:33
  • 2ESC/EAS Guidelines for the management of dyslipidaemias.The task force for the management of dyslipidaemias of the European Society of Cardiology(ESC)and the European Atherosclerosis Society(EAS)[J].Eur Heart J,2011,32:1769-1818.
  • 3陈清杰,杨毅宁.他汀类药物不良反应的研究进展[J].心血管病学进展,2013,34(2):279-283. 被引量:41
  • 4BAUER T,BOHM M,ZAHN R,et al.Effect of chronic stat in pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial ction[J].Cardiovasc Pharmacol,2009,53:132-136.
  • 5SAAB FA,PETRINA M,KLINE-ROGERS E,et al.Early statin therapy in elderly patients presenting with acute coronary syndrome causing less heart failure[J].Indian Heart J,2006,58:321-324.
  • 6MORROW D A,de LEMOS JA,SABATINE M S,et al.Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndrome in the Aggrastat-to-Zocor trial[J].Circulation,2006,114:281-288.
  • 7KIYOKUNI M,KOSUGE M,EBINA T,et al.Effects of pretreatment with statins on infarct size in patients with acute myocardial infarction who receive fibrinolytic therapy[J].Circ J,2009,73:330-335.
  • 8ARONSON D,MUTLAKD,LESSICK J,et al.Relation of statin therapy to risk of heart failure after acute myocardial infarction[J].Am J Cardiol,2008,102:1706-1710.
  • 9BAUER T,BOHM M,ZAHN R,et al.Effect of chronic statin pretreatment on hospital outcome in patients with acutenon-ST-elevationmyocardialinfarction[J].Cardiovasc Pharmacol,2009,53:132-136.
  • 10KIYOKUNI M,KOSUGE M,EBINA T,et al.Effect of Pretreatment with statins on infarct size with acute myocardial infarction who receive fibrinolytic therapy[J].Circ J.2009,73:330-335.

二级参考文献48

  • 1高杰,苏丕雄,张希涛,刘岩,安向光,颜钧,顾松.急诊冠状动脉搭桥术的围手术期处理[J].中国心血管病研究,2006,4(2):99-101. 被引量:4
  • 2苗齐,刘兴荣,王振捷,张恒,张超纪,马国涛,曹丽华.冠状动脉旁路移植手术315例临床分析[J].中国心血管病研究,2006,4(7):534-535. 被引量:3
  • 3[1]Scandinavian Simvastatin Survival Study Group. Randomise d trial of choles terol lowering in 4 444 patients with coronary heart disease: the Scandinavian Survival Study(4S)[J]. Lancet,1994,344:1383-1389.
  • 4[2]Sacks FM,Pfeffer MA,Moye LA,et al. The effect of pravastatin on coro nary events after myocardial infarction in patients with average cholesterol evels. Cholesterol and Recurrent Events Trial Ingestigarors[ J ]. N Engl J Med, 1996,335: 1001-1009.
  • 5[3]The Long-Term Intervention with Pravastatin in Ischemie Heart Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of ini tial cholesterol Levels[J]. N Engl J Med,1998,339:1349-1357.
  • 6[4]Shepherd J,Cobbe SM,Ford 1,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scot[and coronary prevention Study Group[J ]. N Engl J Med, 1995,333: 130l-1307.
  • 7[5]Downs JR,Clearfield M,Weis S,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels Re sults of AFCAPS/Tex CAPS[J]. JAMA,1998,279:1615-1622.
  • 8[6]The lipid research clinics coronary primary prevention trial results. I reduc tion in incidence of coronary heart disease[J]. JAMA. 1984,251: 351-364
  • 9[7]NCEP(National Cholesterol Education Program). Guidelines of the second adult treatment panel( ATP I )[J]. JAMA,1993,267:3015-3023.
  • 10[8]The Post Coronary Artery Bypass Graft Trial Invesugators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts[J ]. N Engl J Med,1997,336:153-162.

共引文献75

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部